LEON KOHANBASH: Open Payments
NPI 1295914869 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,043 in 25 payments from 13 companies in 2025. Trend: 2023 $954 · 2024 $1,350 · 2025 $2,043
Food & beverage: $1,958Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $500 |
| Phathom Pharmaceuticals, Inc. | 4 | $395 |
| Janssen Biotech, Inc. | 2 | $300 |
| AstraZeneca Pharmaceuticals LP | 3 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $168 |
| Lilly USA, LLC | 2 | $144 |
| PFIZER INC. | 1 | $125 |
| Astellas Pharma US Inc | 2 | $118 |
| Seqirus USA Inc | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
Products named: RINVOQ, VOQUEZNA, TREMFYA, Kerendia, MOUNJARO, VELSIPITY, BREZTRI, FARXIGA.
Industry payments across NY — which companies pay providers there.
